ASSESSING THE ROLE OF HIGH-DOSE VITAMIN C IN CRITICALLY ILL PATIENTS WITH COVID-19

Main Article Content

Obaidullah
Akhtar Ali Khan
Tehreem Khan
Niaz Ahmed
Sajjad ul Hasan
Momin Khan

Keywords

COVID-19, High-dose vitamin C, Critically ill, Inflammation, ICU mortality.

Abstract

Introduction: COVID-19 patients in critical condition can suffer a lot of inflammation and oxidative stress, making their prognosis poor. Clinicians propose that HDIVC can be an additional therapy, as its antioxidant and immunomodulatory properties may help patients.


Objective: This study aimed to examine how HDIVC affects the outcomes of critically ill patients with COVID-19.


Materials and Methods: A prospective cohort study was conducted at Department of Pulmonology, Saidu Medical College and Saidu Group of Teaching Hospital Swat, Pakistan, from January, 2024 to June, 2024. Only ill COVID-19 patients treated with usual procedures and either HDIVC or no HDIVC were studied. The team looked at measurable measurements of inflammation and how patients recovered.


Results: After HDIVC administration, the ICU death rate, time spent in the ICU, and mechanical ventilation time were reduced. Among the inflammatory markers, including CRP, D-dimer, and ferritin, levels decreased more in the HDIVC group than in the control group.


Conclusion: HDIVC appears to make treatment safer and more effective for critically ill COVID-19 patients. Repeated larger studies should confirm the results found in this research.

Abstract 171 | Pdf Downloads 46

References

Zhang, J., Rao, X., Li, Y., Zhu, Y., Liu, F., Guo, G., Luo, G., Meng, Z., De Backer, D., Xiang, H. and Peng, Z., 2021. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Annals of intensive care, 11, pp.1-12.
2- JamaliMoghadamSiahkali, S., Zarezade, B., Koolaji, S., SeyedAlinaghi, S., Zendehdel, A., Tabarestani, M., Sekhavati Moghadam, E., Abbasian, L., Dehghan Manshadi, S.A., Salehi, M. and Hasannezhad, M., 2021. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. European journal of medical research, 26, pp.1-9.
3- Sun, L., Zhao, J.H., Fan, W.Y., Feng, B., Liu, W.W., Chen, R.Q., Ban, C., Dang, A.G., Wang, M., Luo, K.T. and Zhou, G.Y., 2024. Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis. Nutrition Reviews, 82(8), pp.1056-1068.
4- Corrao, S., Raspanti, M., Agugliaro, F., Gervasi, F., Di Bernardo, F., Natoli, G. and Argano, C., 2024. Safety of high-dose vitamin C in non-intensive care hospitalized patients with COVID-19: an open-label clinical study. Journal of Clinical Medicine, 13(13), p.3987.
5- Zhao, B., Ling, Y., Li, J., Peng, Y., Huang, J., Wang, Y., Qu, H., Gao, Y., Li, Y., Hu, B. and Lu, S., 2021. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study. Annals of palliative medicine, 10(2), pp.1599609-1591609.
6- Vollbracht, C. and Kraft, K., 2022. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Frontiers in Pharmacology, 13, p.899198.
7- Gavrielatou, E., Xourgia, E., Xixi, N.A., Mantelou, A.G., Ischaki, E., Kanavou, A., Zervakis, D., Routsi, C., Kotanidou, A. and Siempos, I.I., 2022. Effect of vitamin C on clinical outcomes of critically ill patients with COVID-19: an observational study and subsequent meta-analysis. Frontiers in Medicine, 9, p.814587.
8- Gao, D., Xu, M., Wang, G., Lv, J., Ma, X., Guo, Y., Zhang, D., Yang, H., Jiang, W., Deng, F. and Xia, G., 2021. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging (Albany NY), 13(5), p.7020.
9- Bhowmik, K.K., Barek, M.A., Aziz, M.A. and Islam, M.S., 2022. Impact of high‐dose vitamin C on the mortality, severity, and duration of hospital stay in COVID‐19 patients: A meta‐analysis. Health Science Reports, 5(5), p.e762.
10- Labbani-Motlagh, Z., Amini, S., Aliannejad, R., Sadeghi, A., Shafiee, G., Heshmat, R., Jafary, M., Talaschian, M., Akhtari, M., Jamshidi, A. and Mahmoudi, M., 2022. High-dose intravenous vitamin C in early stages of severe acute respiratory syndrome coronavirus 2 infection: a double-blind, randomized, controlled clinical trial. Journal of Research in Pharmacy Practice, 11(2), pp.64-72.
11- Majidi, N., Rabbani, F., Gholami, S., Gholamalizadeh, M., BourBour, F., Rastgoo, S., Hajipour, A., Shadnoosh, M., Akbari, M.E., Bahar, B. and Ashoori, N., 2021. The effect of vitamin C on pathological parameters and survival duration of critically ill coronavirus disease 2019 patients: a randomized clinical trial. Frontiers in immunology, 12, p.717816.
12- Hess, A.L., Halalau, A., Dokter, J.J., Paydawy, T.S., Karabon, P., Bastani, A., Baker, R.E., Balla, A.K. and Galens, S.A., 2022. High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19. Internal and emergency medicine, 17(6), pp.1759-1768.
13- Mahmoodpoor, A., Shadvar, K., Sanaie, S., Hadipoor, M.R., Pourmoghaddam, M.A. and Saghaleini, S.H., 2021. Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study. BMC infectious diseases, 21, pp.1-7.
14- Juneja, D., Gupta, A., Kataria, S. and Singh, O., 2022. Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview. World Journal of Virology, 11(5), p.300.
15- Suna, K., Melahat, U.Ş., Murat, Y., Figen, Ö.E. and Ayperi, Ö., 2022. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia. Medicina Clínica (English Edition), 158(8), pp.356-360.

Most read articles by the same author(s)